Adiponectin in Obese Women With T2DN and Effects by RAS Blocker
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
Insulin resistance typically characterizes type 2 diabetes (T2DM) and prediabetic states and
is the prominent feature of the metabolic syndrome.Adiponectin plays an important part in
glucose metabolism,insulin resistance, the deterioration of renal function.we hypothesize
there is a difference serum adiponectin levels between obese and non-obese women with type 2
diabetic nephropathy. Furthermore, these two groups would respond difference to the RAs
blocker(Losartan).